rs138728350

Positions:

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBS1BS2

The NM_147127.5(EVC2):​c.904T>A​(p.Phe302Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000449 in 1,614,156 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 6 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

2
12
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:3B:4

Conservation

PhyloP100: 4.46
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26599097).
BP6
Variant 4-5665616-A-T is Benign according to our data. Variant chr4-5665616-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 461811.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000821 (125/152278) while in subpopulation AMR AF= 0.00444 (68/15304). AF 95% confidence interval is 0.0036. There are 0 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EVC2NM_147127.5 linkuse as main transcriptc.904T>A p.Phe302Ile missense_variant 8/22 ENST00000344408.10 NP_667338.3 Q86UK5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EVC2ENST00000344408.10 linkuse as main transcriptc.904T>A p.Phe302Ile missense_variant 8/221 NM_147127.5 ENSP00000342144.5 Q86UK5-1
EVC2ENST00000310917.6 linkuse as main transcriptc.664T>A p.Phe222Ile missense_variant 8/221 ENSP00000311683.2 Q86UK5-2
EVC2ENST00000475313.5 linkuse as main transcriptn.664T>A non_coding_transcript_exon_variant 8/231 ENSP00000431981.1 A0A0C4DGE7
EVC2ENST00000509670.1 linkuse as main transcriptn.664T>A non_coding_transcript_exon_variant 9/231 ENSP00000423876.1 E9PFT2

Frequencies

GnomAD3 genomes
AF:
0.000822
AC:
125
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00445
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000537
AC:
135
AN:
251426
Hom.:
2
AF XY:
0.000596
AC XY:
81
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000784
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000624
Gnomad OTH exome
AF:
0.00358
GnomAD4 exome
AF:
0.000410
AC:
600
AN:
1461878
Hom.:
6
Cov.:
32
AF XY:
0.000443
AC XY:
322
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000939
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00110
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000334
Gnomad4 OTH exome
AF:
0.000695
GnomAD4 genome
AF:
0.000821
AC:
125
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.000886
AC XY:
66
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.000192
Gnomad4 AMR
AF:
0.00444
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000632
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000914
Hom.:
1
Bravo
AF:
0.00144
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000560
AC:
68
EpiCase
AF:
0.00142
EpiControl
AF:
0.00119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
EVC2-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 04, 2024The EVC2 c.904T>A variant is predicted to result in the amino acid substitution p.Phe302Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.078% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 02, 2018- -
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Ellis-van Creveld syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaSep 24, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Uncertain
0.018
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.77
D;.
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.048
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.78
T;T
M_CAP
Uncertain
0.094
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Uncertain
2.6
M;.
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-2.8
D;D
REVEL
Uncertain
0.47
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0060
D;D
Polyphen
1.0
D;.
Vest4
0.75
MVP
0.72
MPC
0.18
ClinPred
0.070
T
GERP RS
4.1
Varity_R
0.37
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138728350; hg19: chr4-5667343; COSMIC: COSV60396645; API